BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Medpace Holdings Announces Commencement of Proposed Secondary Offering of Common Stock by Selling Shareholder

  Jefferies LLC and Credit Suisse Securities (USA) LLC are acting as bookrunners for the offering.

  November 27, 2017

   · 

  2 min read
• Business

  Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor

  The appointment further strengthens CEGX’s panel of opinion leaders providing expert advice across the Company’s key focus areas of epigenetics, oncology, liquid biopsy, diagnostic and therapeutic development.

  November 27, 2017

   · 

  2 min read
• Drug Development

  Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies

  The study found that OA/US was more specific than device gray-scale ultrasound alone in differentiating malignant from benign breast lesions and was non-inferior to US with respect to sensitivity.

  November 27, 2017

   · 

  6 min read
• Business

  HITGEN and Boehringer Ingelheim Enter DNA-Encoded Library Based Drug Discovery Research Collaboration

  HitGen will receive upfront payments, and be eligible for milestone payments from Boehringer Ingelheim. Specific financial details were not disclosed.

  November 27, 2017

   · 

  2 min read
• 

  Biotech Beach

  San Diego’s Biolinq Scores $10M Series A

  Biolinq’s first commercial product will allow patients with diabetes to continuously monitor their blood glucose without the pain and hassle of traditional continuous glucose monitoring systems.

  November 27, 2017

   · 

  3 min read
• 

  Business

  Biogen Forges $278M MS Tie-Up With Alkermes

  Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700.

  November 27, 2017

   · 

  12 min read
• Drug Development

  Kalytera Announces Second U.S. Patent for Prevention and Treatment of Graft Versus Host Disease

  Kalytera’s Phase 2 study is expected to enroll 36 patients following allogeneic hematopoietic cell transplantation (“HCT”), commonly referred to as bone marrow transplantation.

  November 27, 2017

   · 

  5 min read
• Policy

  Benitec Biopharma Provides Update on OPMD Orphan Disease Program

  In addition, over the past several weeks, the Benitec team has now completed pre-IND and scientific advice meetings with the U.S. FDA, Health Canada and several European agencies.

  November 27, 2017

   · 

  6 min read
• BioMidwest

  Sigmascreening Showcases Sensitive Sigma Paddle at RSNA

  Based on breast-size and tissue-stiffness the Sensitive Sigma Paddle calculates the pressure to achieve an optimal compression of 75mmHg and allows for a highly reproducible procedure.

  November 27, 2017

   · 

  3 min read
• Drug Development

  Eureka Announces FDA Allowance of Investigational New Drug Application for ET190L1-ARTEMIS™ T cell Therapy in Relapsed and Refractory CD19+ Non-Hodgkin Lymphoma

  In preclinical studies, ET190L1-ARTEMIS matched the cancer killing potency of current CAR-T therapies but with a dramatic reduction in the levels of inflammatory cytokines released

  November 27, 2017

   · 

  3 min read